Physician profile
Jason Scott Lipof
NPI 1114312519
$50,978.74
in general payments reported to CMS, 2019-2025
22 companies · $30K in 2025
The $30K reported for 2025 was more than what 85% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,137 · 2022: $7,298 · 2023: $1,197 · 2024: $5,186 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $4,786 · Consulting Fee: $3,080 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $23,830.30 |
| Food and Beverage | $4,786.28 |
| Consulting Fee | $3,080.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $2,346.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $27,631.81 | 2021-2025 | Dvr Anatomic Kickstand, Persona, Affixus |
| Smith+Nephew, INC. | $12,469.91 | 2021-2025 | Real Intelligence, Renasys Go V2 Home, Pico |
| Medical Device Business Services, INC. | $3,225.02 | 2025 | Kincise, Emphasys, Reclaim |
| Arthrex, INC. | $2,500.00 | 2024 | |
| Skeletal Dynamics INC | $2,284.40 | 2021-2024 | Align, Implate, Ijs |
| Stryker Corporation | $664.62 | 2022-2025 | Mako, Insignia, Triathlon |
| Onkos Surgical, INC. | $429.04 | 2024-2025 | Eleos Limb Salvage System |
| Depuy Synthes Sales INC. | $356.28 | 2021-2025 | Na |
| Ethicon US, LLC | $221.42 | 2024 | Vistaseal, Dermabond Prineo |
| Davol INC. | $183.47 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $143.82 | 2025 | |
| Encore Medical, LP | $127.90 | 2023-2025 | Djo Surgical |
| Biocomposites INC | $115.34 | 2024 | |
| Lifenet Health | $115.13 | 2022 | |
| Baxter Healthcare | $111.13 | 2023-2024 | Tisseel, Perclot |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curvafix, INC. | $106.80 | 2024 | Curvafix Im Implant |
| Uoc USA INC | $96.00 | 2021 | |
| Prodigy Surgical Distribution, INC. | $55.31 | 2024 | |
| Osteocentric Technologies, INC. | $49.78 | 2023-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Bioventus LLC | $44.86 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Evolution Surgical, INC | $29.18 | 2025 | |
| Solventum Corporation | $17.52 | 2024 | Bair Paws, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lipof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.